Hiroaki Mitsuya
教授
National Cancer Institute;Departments of Hematology and Rheumatology
School of Medicine, Kumamoto University;Division of Infectious Diseases, School of Medicine, Kumamoto University;International Center for Clinical Research, National Center for Global Health and Medicine
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:234
职业迁徙
个人简介
In 1984, Dr. Mitsuya steered his attention to human immunodeficiency virus or HIV and played a critical role in the discovery and development of the first three drugs for AIDS and HIV infection [zidovudine (AZT), didanosine (ddI), and zalcitabine (ddC)]. Dr. Mitsuya has since been a leading researcher in the area of development of AIDS therapeutics and study of HIV resistance. Recently he has played a major role in the discovery and development of the next generation anti-HIV drug, darunavir.
研究兴趣
论文共 513 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Proceedings of the National Academy of Sciences of the United States of Americano. 37 (2024): e2404175121-e2404175121
ACS infectious diseasesno. 6 (2024): 2250-2261
Journal of virologyno. 3 (2024): e0182323-e0182323
Organic & biomolecular chemistryno. 36 (2024): 7354-7372
Journal of Infectionno. 1 (2024): 106179-106179
Arun K. Ghosh,Monika Yadav, Satyanarayana Iddum, Somayeh Ghazi,Emma K. Lendy, Uttara Jayashankar, Sydney N. Beechboard,Yuki Takamatsu,Shin-ichiro Hattori, Masayuki Aamano,Nobuyo Higashi-Kuwata,Hiroaki Mitsuya,Andrew D. Mesecar
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)
Mari Shimura,Nobuyo Higashi-Kuwata,Asuka Fujiwara, Mai Taniguchi,Takayuki Ichinose,Fumie Hamano,Masaaki Uematsu,Takato Inoue,Satoshi Matsuyama, Takahiro Suzuki,Arun K. Ghosh,Hideo Shindou, Takao Shimuzu,Hiroaki Mitsuya
Antiviral research (2024): 105819-105819
Scientific reportsno. 1 (2024): 15742-15742
加载更多
作者统计
#Papers: 512
#Citation: 16365
H-Index: 60
G-Index: 109
Sociability: 7
Diversity: 0
Activity: 3
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn